核子医学市场：按类型、应用程式、最终用户和地区划分

核医市场规模预计在 2025 年达到 183.2 亿美元，预计到 2032 年将达到 385.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 11.2%。

近年来，受慢性病发病率上升、核医学技术进步以及个人化医疗需求不断增长的推动，全球核医市场取得了显着成长。核子医学涉及使用放射性物质进行诊断和治疗，从而能够早期发现和治疗各种疾病，包括癌症、心血管疾病和神经系统疾病。该市场涵盖广泛的产品和服务，包括放射性药物、影像设备和软体解决方案，以满足全球医疗专业人员和患者的多样化需求。随着医疗保健产业的不断发展和创新技术的采用，核医市场未来将进一步扩张和发展。

市场动态

全球核子医学市场受到几个关键驱动因素、市场限制因素和市场机会的影响。其中一个关键驱动因素是癌症和心血管疾病等慢性疾病的发生率不断上升，这些疾病需要先进的诊断和治疗性介入。此外，由于老年人更容易患与老龄化相关的疾病，预计全球老年人口的增长将推动对核医学程序的需求。包括混合成像模式的开发和新型放射性药物的引入在内的技术进步也在透过提高核医学程序的准确性和效率来推动市场成长。然而，市场面临某些限制，例如核医设备的高成本以及对放射性药物的核准和使用的严格监管要求。缺乏接受过核子医学技术培训的熟练专业人员也是市场成长的挑战。儘管有这些市场限制，核医市场仍提供了巨大的成长机会，特别是在对先进医疗服务需求不断增长的新兴国家。核子医学在阿兹海默症和帕金森氏症等神经系统疾病的诊断和治疗中的应用日益广泛，这是市场扩张的另一个有希望的机会。

本报告的主要特点

• 本报告对全球核子医学市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
• 它还强调了每个细分市场的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球核子医学市场的主要企业是根据以下参数列出的，例如公司概况、产品系列、主要亮点、财务表现和策略。
• 透过本报告的见解，负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
• 「全球核子医学市场」报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球核子医学市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 分析目标与前提条件

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 限制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特五力分析
• 企业合併（M&A）场景
• 产业趋势

第四章。全球核子医学市场按类型划分（以金额为准，2020-2032 年）

• 诊断核子医学
• 治疗性核子医学

5. 全球核子医学市场按应用划分（以金额为准，2020-2032）

• 瘤
• 心臟病
• 神经症
• 内分泌失调
• 骨转移
• 胃肠病学
• 呼吸系统
• 感染疾病
• 其他的

6. 全球核子医学市场按最终用户划分（以金额为准，2020-2032 年）

• 医院和诊所
• 诊断中心
• 实验室
• 学术机构
• 其他的

7. 全球核子医学市场按地区划分（以金额为准，2020-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第八章 竞争态势

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Toshiba Medical Systems
• Bracco Imaging
• Canon Medical Systems
• EczacA+-baAYA+ - Monrol
• Mallinckrodt Pharmaceuticals
• Lantheus Medical Imaging
• Bayer AG
• RadioMedix
• IBA Radiopharma Solutions
• Nordion（a Sotera Health company）
• Advanced Accelerator Applications
• Actinium Pharmaceuticals

第九章 分析师建议

• “命运之轮”
• 分析师观点
• Coherent Opportunity Map (COM)

第十章参考文献与调查方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Nuclear Medicine Market is estimated to be valued at USD 18.32 Bn in 2025 and is expected to reach USD 38.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

The global nuclear medicine market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, advancements in nuclear medicine technology, and the growing demand for personalized medicine. Nuclear medicine involves the use of radioactive substances for diagnostic and therapeutic purposes, enabling the early detection and treatment of various diseases, including cancer, cardiovascular disorders, and neurological conditions. The market encompasses a wide range of products and services, such as radiopharmaceuticals, imaging equipment, and software solutions, catering to the diverse needs of healthcare professionals and patients worldwide. As the healthcare industry continues to evolve and embrace innovative technologies, the nuclear medicine market is poised for further expansion and development in the coming years.

Market Dynamic

The global nuclear medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of chronic diseases, such as cancer and cardiovascular disorders, which require advanced diagnostic and therapeutic interventions. Additionally, the growing geriatric population worldwide is expected to fuel the demand for nuclear medicine procedures, as older individuals are more susceptible to age-related diseases. Technological advancements, including the development of hybrid imaging modalities and the introduction of novel radiopharmaceuticals, are also driving market growth by improving the accuracy and efficiency of nuclear medicine procedures. However, the market faces certain restraints, such as the high cost of nuclear medicine equipment and the stringent regulatory requirements for the approval and use of radiopharmaceuticals. The shortage of skilled professionals trained in nuclear medicine techniques also poses a challenge to market growth. Despite these restraints, the nuclear medicine market presents significant opportunities for growth, particularly in emerging economies, where there is a rising demand for advanced healthcare services. The increasing adoption of nuclear medicine in the diagnosis and treatment of neurological disorders, such as Alzheimer's and Parkinson's disease, is another promising opportunity for market expansion.

Key Features of the Study

• This report provides in-depth analysis of the global nuclear medicine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global nuclear medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Bracco Imaging, Canon Medical Systems, EczacIbasI-Monrol, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging, Bayer AG, RadioMedix, IBA Radiopharma Solutions, Nordion (a Sotera Health company), Advanced Accelerator Applications, and Actinium Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine market

Market Segmentation

• Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • Tc-99m
  • I-123
  • Tl-201
  • Ga-67
  • Other SPECT Isotopes
  • PET Radiopharmaceuticals
  • F-18
  • Rb-82
  • Other PET Isotopes
  • Therapeutic Nuclear Medicine
  • Alpha Emitters
  • Ra-223
  • Beta Emitters
  • I-131
  • Y-90
  • Sm-153
  • Lu-177
  • Re-186
  • Other Beta Emitters
  • Brachytherapy Isotopes
  • Cesium-131
  • Iodine-125
  • Palladium-103
  • Iridium-192
  • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Cardiology
  • Neurology
  • Endocrinology
  • Bone Metastasis
  • Gastroenterology
  • Pulmonology
  • Infectious Diseases
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals & Clinics
  • Diagnostic Centers
  • Research Laboratories
  • Academic Institutions
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Toshiba Medical Systems
  • Bracco Imaging
  • Canon Medical Systems
  • EczacIbasI-Monrol
  • Mallinckrodt Pharmaceuticals
  • Lantheus Medical Imaging
  • Bayer AG
  • RadioMedix
  • IBA Radiopharma Solutions
  • Nordion (a Sotera Health company)
  • Advanced Accelerator Applications
  • Actinium Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Nuclear Medicine Market, By Type
  • Global Nuclear Medicine Market, By Application
  • Global Nuclear Medicine Market, By End User
  • Global Nuclear Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Nuclear Medicine Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostic Nuclear Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • SPECT Radiopharmaceuticals
      • Tc-99m
      • I-123
      • Tl-201
      • Ga-67
      • Other SPECT Isotopes
    • PET Radiopharmaceuticals
      • F-18
      • Rb-82
• Therapeutic Nuclear Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Alpha Emitters
      • Ra-223
    • Beta Emitters
      • I-131
      • Y-90
      • Sm-153
      • Lu-177
      • Re-186
      • Other Beta Emitters
    • Brachytherapy Isotopes
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192
      • Others

5. Global Nuclear Medicine Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bone Metastasis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastroenterology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pulmonology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Nuclear Medicine Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Nuclear Medicine Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Toshiba Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bracco Imaging
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EczacA+-baAYA+--Monrol
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mallinckrodt Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lantheus Medical Imaging
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• RadioMedix
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IBA Radiopharma Solutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nordion (a Sotera Health company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Accelerator Applications
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Actinium Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us